Vosodilator buflomedil injection to be banned

Published: 2011-12-07 06:56:00

Updated: 2011-12-07 06:56:00

The Korea Food and Drug Administration (KFDA) said yesterday it has decided to ban sales of buflomedil-containing drugs, mostly used to treat peripheral arterial occlusive disease, following the sales ban of oral buflomedil products in August.

The ban came after the European Medicines Agency (...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK